4
Changes in Ownership
Scribe Therapeutics, Inc. Filed Acc 0000902664-26-003270
Director bought 2,391,238 shares at an average $15.16 ($36,259,761)
From the SEC's structured data for this filing
Trades in this filing
Aghazadeh Behzad · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-24 | Purchase : show line 1 in the form | +2,333,333 | $15.00 | $34,999,995 | 3,030,983 | I |
| 2026-07-24 | Purchase : show line 2 in the form | +50,000 | $22.31 | $1,115,500 | 3,080,983 | I |
| 2026-07-28 | Purchase : show line 3 in the form | +7,905 | $18.25 | $144,266 | 3,088,888 | I |
| Open-market purchases · 2,391,238 sh · avg $15.16 · $36,259,761 | ||||||
Loading xslF345X06/ownership.xml…